Skip to content

Profile Picture
Mobile
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
  • Tools
SafeSearch
Info Icon Safe Search
Cross Icon Toggle
Strict Mode
Block all adult content from results.
Moderate Mode
Block adult images and videos but allow adult text.
Off Mode
Show everything, even if it's explicit.
About 1,800 results
Safe Search Moderate
Open links in new tab
Any time
  1. avmapkifakzynjaco-pack.com
    https://www.avmapkifakzynjaco-pack.com

    AVMAPKI™ FAKZYNJA™ CO-PACK | Patient Information

    AVMAPKI FAKZYNJA CO-PACK is a prescription medicine used to treat adults who have low-grade serous ovarian cancer (LGSOC) that has come back (recurrent), and LGSOC with an …

  2. verastem.com
    https://investor.verastem.com › news-releases › news...

    FDA Approves the AVMAPKI™ FAKZYNJA™ Combination Therapy …

    May 8, 2025 · AVMAPKI FAKZYNJA CO-PACK is the first treatment to receive regulatory approval anywhere in the world, specifically for KRAS-mutated recurrent LGSOC. The …

  3. avmapkifakzynjaco-pack-hcp.com
    https://www.avmapkifakzynjaco-pack-hcp.com

    AVMAPKI™ FAKZYNJA™ CO-PACK | Official HCP Resource

    AVMAPKI FAKZYNJA CO-PACK is indicated for the treatment of adult patients with KRAS -mutated recurrent low-grade serous ovarian cancer (LGSOC) who have received prior …

  4. fda.gov
    https://www.fda.gov › drugs › resources-information...

    FDA grants accelerated approval to the combination of avutometinib

    On May 8, 2025, the Food and Drug Administration granted accelerated approval to the combination of avutometinib and defactinib (Avmapki Fakzynja Co-pack, Verastem, Inc.) for …

  5. drugs.com
    https://www.drugs.com › avmapki-fakzynja.html

    Avmapki Fakzynja Co-Pack - Drugs.com

    May 27, 2025 · Avmapki Fakzynja Co-Pack is a prescription medicine used for recurrent low-grade serous ovarian cancer (LGSOC) in adult patients with KRAS mutations. Avmapki …

  6. optumrx.com
    https://professionals.optumrx.com › ... › pdfs
    [PDF]

    AvmapkiTM FakzynjaTM Co-Pack (avutometinib; defactinib

    On May 8, 2025, the FDA announced the approval of Verastem’s Avmapki Fakzynja Co-Pack (avutometinib; defactinib), for the treatment of adult patients with KRAS-mutated recurrent low …

  7. webmd.com
    https://www.webmd.com › drugs › avmapki...

    Avmapki Fakzynja Co-Pack (avutometinib and defactinib) - WebMD

    May 14, 2025 · Overview: Avmapki Fakzynja Co-Pack is used to treat ovarian cancer in certain people. It contains two medicines that work together to slow the growth of cancer cells. The …

  8. rxlist.com
    https://www.rxlist.com › avmapki-drug.htm

    Avmapki Fakzynja Co-Pak (avutometinib): Side Effects, Uses

    May 23, 2025 · Avmapki Fakzynja Co-Pack (avutometinib capsules; defactinib tablets) is a combination of avutometinib and defactinib, each kinase inhibitors, indicated for the treatment …

  9. mckesson.com
    https://biologics.mckesson.com › avmapki-fakzynja-co...

    AVMAPKI™ FAKZYNJA™ CO-PACK (avutometinib capsules; …

    May 9, 2025 · AVMAPKI FAKZYNJA CO-PACK, approved by the U.S. Food and Drug Administration (FDA) on May 8, 2025, is a novel combination of AVMAPKI (avutometinib …

  10. nih.gov
    https://dailymed.nlm.nih.gov › dailymed › lookup.cfm

    DailyMed - AVMAPKI FAKZYNJA CO-PACK- avutometinib …

    May 1, 2025 · AVMAPKI FAKZYNJA CO-PACK is indicated for the treatment of adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC) who have received prior …

  11. Pagination

    • 1
    • 2
    • 3
    • 4
    • Next
      © 2025 Microsoft
      • Privacy and Cookies
      • Legal
      • Advertise
      • About our ads
      • Help
      • Feedback
      • Consumer Health Privacy
      AllPast 24 hoursPast weekPast monthPast year